AnalystBro Research
Research
Company valuation reports, peer comparisons, results notes, industry reports and macro views, built from company filings and official data and independently reviewed before publishing. Company reports show their full model as view-only sheets. Facts and estimates, not investment advice.
2 articles.
Bangladesh All Bangladesh research →
Company · DSE:SALVO · Chemicals · Analysis · 31 Oct 2026
Salvo Organic Industries: FY2026 revenue of BDT 3,113.6m, gross margin of 9.6% and a qualified audit; bank borrowings down to BDT 618.8m
Revenue rose in 6 of the 7 years FY2020-FY2026, to BDT 3,113.6m in the year to 30-Jun-2026. Gross margin was 29.6% in FY2019 and 9.6% in FY2026. Financial charges were 53.3% of profit from operation in FY2026. The auditor qualified the FY2026 accounts on the employee-benefit funds.
Company · DSE:WATACHEM · Chemicals · Analysis · 31 Oct 2026
WATA Chemicals: finance expenses took 92.8% of FY2025 operating profit; a qualified FY2025 audit and FY2026 EPS of BDT 2.08 announced on DSE
The sulphuric acid and alum maker earned an operating profit of BDT 202.4m in FY2025 and paid finance expenses of BDT 187.9m, leaving profit after tax of BDT 11.0m. The auditor qualified the FY2025 accounts on five bases. The company announced FY2026 EPS of BDT 2.08 and a 15% cash dividend on 29-Oct-2026; the FY2026 audited report is not in the corpus at 1-Nov-2026.